Quince Therapeutics Announces Pricing of Up to $22 Million Private Placement of Securities

Stock Information for Quince Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Quince Therapeutics Inc.

Quince Therapeutics to Participate at A-T Society's 2025 A-T Clinical Research Conference
Quince Therapeutics Announces Closing of Up to $22 Million Private Placement of Securities
Quince Therapeutics Exceeds 75% Enrollment in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia
Quince Therapeutics Provides Business Update and Reports First Quarter 2025 Financial Results
Quince Therapeutics to Present at Citizens Life Sciences Conference
Quince Therapeutics to Present at Jones Healthcare and Technology Innovation Conference
Quince Therapeutics Provides Business Update and Reports Fiscal Year 2024 Financial Results
Quince Therapeutics to Host Investor Webinar Today Focused on Addressing the High Unmet Need in Ataxia-Telangiectasia

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.